Lixiana 30 mg film-coated tablets

DRUG5 trials

Sponsors

St Antonius Hospital, Medical University Of Vienna, University Hospital Zurich, Hamilton Health Sciences Corporation, PHRI Population Health Research Institute International, St. Antonius Ziekenhuis

Conditions

Acute ischemic strokeAtrial fibrillation Acute coronary syndrome Chronic coronary syndromeChronic Thromboembolic Disease (CTED) without Pulmonary HypertensionChronic Thromboembolic Pulmonary Hypertension (CTEPH)High risk atrial fibrillation patients with previous intracranial hemorrhagePorto-Sinusoidal Vascular Disorder

Phase 2

Prospective, randomized, double-blind, placebo-controlled, crossover phase IIa study on the safety of EdoXaban in PortosinusOidal vaScUlar disorder (EXPOSURE)

RecruitingCTIS2024-513353-73-00

Medical University Of ViennaPorto-Sinusoidal Vascular Disorder

Start: 2025-04-04Target: 56Updated: 2025-01-31

Phase 3

MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study. An international, multicentre, randomised-controlled, two-arm, assessor-blinded trial.

Not yet recruitingCTIS2024-517600-11-01

University Hospital ZurichAcute ischemic stroke

Target: 190Updated: 2025-01-23

Phase 4

What is the optimal antithrombotic strategy in patients with atrial fibrillation having acute coronary syndrome or undergoing percutaneous coronary intervention?

RecruitingCTIS2022-502140-13-00

St Antonius HospitalAtrial fibrillation Acute coronary syndrome Chronic coronary syndrome

Start: 2023-01-11Target: 3000Updated: 2026-01-26

Anticoagulant medicines for Balloon Pulmonary Angioplasty

Not yet recruitingCTIS2024-518803-23-00

St. Antonius ZiekenhuisChronic Thromboembolic Disease (CTED) without Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Target: 84Updated: 2024-12-03

EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation

Not yet recruitingCTIS2024-518508-31-00

Hamilton Health Sciences Corporation, PHRI Population Health Research Institute InternationalHigh risk atrial fibrillation patients with previous intracranial hemorrhage

Target: 380Updated: 2025-10-20